These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 31216743

  • 21. A retrospective analysis using Monte Carlo simulation to evaluate recommended ceftazidime dosing regimens in healthy volunteers, patients with cystic fibrosis, and patients in the intensive care unit.
    Mouton JW, Punt N, Vinks AA.
    Clin Ther; 2005 Jun; 27(6):762-72. PubMed ID: 16117983
    [Abstract] [Full Text] [Related]

  • 22. Plasma concentrations and effects of salbutamol administered orally to patients with cystic fibrosis.
    Demnati R, Michoud MC, Jeanneret-Grosjean A, Ong H, Du Souich P.
    Br J Clin Pharmacol; 1995 Oct; 40(4):319-24. PubMed ID: 8554933
    [Abstract] [Full Text] [Related]

  • 23. Cefepime pharmacokinetics in cystic fibrosis.
    Hamelin BA, Moore N, Knupp CA, Ruel M, Vallée F, LeBel M.
    Pharmacotherapy; 1993 Oct; 13(5):465-70. PubMed ID: 8247913
    [Abstract] [Full Text] [Related]

  • 24. Effects of Pseudomonas colonization on body composition and resting energy expenditure in children with cystic fibrosis.
    Vinton NE, Padman R, Davis M, Harcke HT.
    JPEN J Parenter Enteral Nutr; 1999 Oct; 23(4):233-6. PubMed ID: 10421394
    [Abstract] [Full Text] [Related]

  • 25. Pharmacokinetics of single-dose doripenem in adults with cystic fibrosis.
    Cirillo I, Vaccaro N, Redman R, Black PL, Kearns GL.
    J Clin Pharmacol; 2012 Nov; 52(11):1645-53. PubMed ID: 22174436
    [Abstract] [Full Text] [Related]

  • 26. Drug disposition in cystic fibrosis.
    Rey E, Tréluyer JM, Pons G.
    Clin Pharmacokinet; 1998 Oct; 35(4):313-29. PubMed ID: 9812180
    [Abstract] [Full Text] [Related]

  • 27. Insulin-like growth factor-1, leptin, body composition, and clinical status interactions in children with cystic fibrosis.
    Boguszewski MC, Kamoi TO, Bento Radominski R, Boguszewski CL, Rosberg S, Filho NA, Sandrini Neto R, Albertsson-Wikland K.
    Horm Res; 2007 Oct; 67(5):250-6. PubMed ID: 17215581
    [Abstract] [Full Text] [Related]

  • 28. Increased nonrenal clearance and increased diuretic efficiency of furosemide in cystic fibrosis.
    Alván G, Beermann B, Hjelte L, Lind M, Lindholm A, Strandvik B.
    Clin Pharmacol Ther; 1988 Oct; 44(4):436-41. PubMed ID: 3168395
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Clinical pharmacokinetics of antimicrobial drugs in cystic fibrosis.
    Touw DJ.
    Pharm World Sci; 1998 Aug; 20(4):149-60. PubMed ID: 9762727
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Pharmacokinetic and Pharmacodynamic Analyses of Ceftaroline in Adults with Cystic Fibrosis.
    Autry EB, Rybak JM, Leung NR, Gardner BM, Burgess DR, Anstead MI, Kuhn RJ.
    Pharmacotherapy; 2016 Jan; 36(1):13-8. PubMed ID: 26748559
    [Abstract] [Full Text] [Related]

  • 39. Pharmacokinetics of vancomycin in adult cystic fibrosis patients.
    Pleasants RA, Michalets EL, Williams DM, Samuelson WM, Rehm JR, Knowles MR.
    Antimicrob Agents Chemother; 1996 Jan; 40(1):186-90. PubMed ID: 8787903
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.